MedPath
NMPA Approval

Selexipag Tablets

国药准字H20249718

December 10, 2024

Drug Information

司来帕格片

片剂

0.2mg

化学药品

December 10, 2024

Company Information

Applicant Company

江苏省连云港经济技术开发区

Manufacturing Company

连云港经济技术开发区庐山路8号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

司来帕格片 - NMPA 批准文号 | MedPath